RETAVASE

Ekr Therapeutics, Inc.

Application Filed: 2019-03-15

Trademark Application Details

Mark For: RETAVASE® trademark registration is intended to cover the categories of cardiovascular agents for medical purposes, namely, a recombinant plasminogen activator compound for use in the management of acute myocardial infarction. [all]

Status

2020-07-15 UTC

LIVE REGISTRATION Issued and Active

The trademark application has been registered with the Office.

Research	OneLook Acronym Finder
Serial Number	88341695
Registration Number	5857585
Mark Literal Elements	RETAVASE
Mark Drawing Type	4 - STANDARD CHARACTER MARK
Mark Type	TRADEMARK
Register	PRINCIPAL
Current Location	PUBLICATION AND ISSUE SECTION 2019-09-10
Basis	1(a)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	Yes
Current Use	Yes
Intent To Use	No
Filed ITU	No
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Matthew Hintz
Attorney Docket Number	19015.239
Law Office Assigned	L90
Employee Name	RATCLIFFE, ROBERT L

Timeline

1997-01-02	Date of First Use
1997-01-02	Date of Use In Commerce
2019-03-15	Application Filed
2019-05-01	Location: TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
2019-05-01	Status: Live/Pending
2019-05-16	Transaction Date
2019-06-25	Published
2019-06-25	Published for Opposition
2019-09-10	Location: PUBLICATION AND ISSUE SECTION
2019-09-10	Status: Registered. The registration date is used to determine when post-registration maintenance documents are due.
2019-09-10	Trademark Registered

Trademark Parties (Applicants & Owners)

Party:	EKR THERAPEUTICS, INC.
Address	175 Regency Woods Place, Suite 600 Cary, NORTH CAROLINA UNITED STATES 27518
Legal Entity Type	Corporation
Legal Entity State	DELAWARE

Documents

Drawing	JPEG	2019-03-15
Specimen	JPEG	2019-03-15
TEAS RF New Application	MULTI	2019-03-15
Request to Make Special	XML	2019-03-20
Petition Decision	XML	2019-04-23
Examiners Amendment	XML	2019-04-29
Notation to File	XML	2019-04-29
XSearch Search Summary	XML	2019-04-29
Amendment and Mail Process Complete	MULTI	2019-04-30
TRAM Snapshot of App at Pub for Oppostn	MULTI	2019-05-02
Notice of Publication	XML	2019-06-05
Notification Of Notice of Publication	XML	2019-06-05
OG Publication Confirmation	APPLICATION/XML	2019-06-25
Registration Certificate	PDF	2019-09-10

Attorney of Record

MATTHEW HINTZ
LOWENSTEIN SANDLER LLP
ONE LOWENSTEIN DRIVE
ROSELAND, NJ 07068

Good, Services, and Codes

IC 005. US 006 018 044 046 051 052. G & S: cardiovascular agents for medical purposes, namely, a recombinant plasminogen activator compound for use in the management of acute myocardial infarction. FIRST USE: 19970102. FIRST USE IN COMMERCE: 19970102

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	cardiovascular agents for medical purposes, namely, a recombinant plasminogen activator compound for use in the management of acute myocardial infarction
GS0051	cardiovascular agents for medical purposes, namely, a recombinant plasminogen activator compound for use in the management of acute myocardial infarction

Trademark Filing History

Description	Date	Proceeding Number
REGISTERED-PRINCIPAL REGISTER	2019-09-10
PUBLISHED FOR OPPOSITION	2019-06-25
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2019-06-25
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2019-06-05
ASSIGNED TO LIE	2019-05-16	68552
APPROVED FOR PUB - PRINCIPAL REGISTER	2019-05-01
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2019-04-29	6328
EXAMINERS AMENDMENT E-MAILED	2019-04-29	6328
EXAMINERS AMENDMENT -WRITTEN	2019-04-29	94057
EXAMINER'S AMENDMENT ENTERED	2019-04-29	88888
REQUEST FOR SPECIAL HANDLING - GRANTED	2019-04-23	67832
ASSIGNED TO EXAMINER	2019-04-23	88577
ASSIGNED TO PETITION STAFF	2019-04-18	67832
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2019-04-03
TEAS REQUEST TO MAKE SPECIAL RECEIVED	2019-03-20	1111
NEW APPLICATION ENTERED IN TRAM	2019-03-19

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
RETAVASE 88341695 not registered Live/Pending	EKR THERAPEUTICS, INC. 2019-03-15
RETAVASE 75324869 2175074 Dead/Cancelled	EKR THERAPEUTICS, INC. 1997-07-15
RETAVASE 74647641 not registered Dead/Abandoned	BOEHRINGER MANNHEIM PHARMACEUTICALS CORPORATION 1995-03-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.